SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-20-009843
Filing Date
2020-04-22
Accepted
2020-04-22 17:05:11
Documents
12

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 ea120833-posama2_adialpharma.htm POS AM 1736818
2 CONSENT OF FRIEDMAN LLP ea120833ex23-1_adialpharma.htm EX-23.1 1874
3 GRAPHIC image_001.jpg GRAPHIC 28157
4 GRAPHIC image_002.jpg GRAPHIC 108341
5 GRAPHIC image_003.jpg GRAPHIC 42642
6 GRAPHIC image_004.jpg GRAPHIC 46115
7 GRAPHIC image_005.jpg GRAPHIC 108565
8 GRAPHIC image_006.jpg GRAPHIC 77486
9 GRAPHIC image_007.jpg GRAPHIC 46115
10 GRAPHIC image_008.jpg GRAPHIC 47298
11 GRAPHIC image_009.jpg GRAPHIC 58866
12 GRAPHIC backcover.jpg GRAPHIC 6146
  Complete submission text file 0001213900-20-009843.txt   2525854
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-220368 | Film No.: 20808493
SIC: 2834 Pharmaceutical Preparations